Study of HS-20152 in healthy volunteers
This trial tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. Participants will receive vaccinations before the study to protect against certain infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 64 years old.
- You need a body mass index (BMI) between 19 and 28, and weigh at least 45 kg (female) or 50 kg (male).
- Women and men must agree to use effective birth control from before the study until 6 months after the last dose.
- You must be willing to get vaccines for meningitis and pneumonia at least 2 weeks before the first dose.
- You must avoid caffeine, alcohol, grapefruit, and certain other foods and drinks before dosing.
- You cannot have certain medical conditions, infections, or use other medications that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This trial tests a new drug called HS-20136-2 in healthy people to see how it works in the body and if it's safe. It's a Phase 1 study to gather early information before testing in patients.
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial is testing a new medicine called SSS55 in healthy adults to see if it is safe and how the body processes it. Participants will receive meningococcal and pneumococcal vaccines before the study.
This trial tests a single dose of a new medicine called HB0056 in healthy volunteers to evaluate its safety and how the body processes it. If you are a healthy adult, you may help doctors understand if this drug is safe for future studies.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.